Patents by Inventor Ludovic HALBY

Ludovic HALBY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEMI-SYNTHETIC TRILOBINE ANALOGS FOR USE AS A DRUG
    Publication number: 20190062339
    Abstract: The invention concerns a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof as well as a pharmaceutical composition containing such a compound, and the use of such a compound as a drug, notably as a DNMT inhibitor, in particular in the treatment of cancer.
    Type: Application
    Filed: October 3, 2016
    Publication date: February 28, 2019
    Applicants: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Ludovic HALBY, Yoann MENON, El Bachir KALOUN, Christophe LONG, Paola B. ARIMONDO
  • QUINAZOLINE DERIVATIVES AND THEIR USE AS DNA METHYLTRANSFERASE INHIBITORS
    Publication number: 20160229834
    Abstract: The present invention relates to compounds of the following formula (I): and pharmaceutically acceptable salts and solvates thereof, their methods of preparation, their use as a drug, notably in the treatment of cancer, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: September 19, 2014
    Publication date: August 11, 2016
    Applicants: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Ludovic HALBY, Paola Barbara ARIMONDO